Javascript must be enabled for the correct page display

The cost-effectiveness of ARGX-113 as second line treatment for adult chronic primary immune thrombocytopenia in the United Kingdom.

Fledderus, R.H.M. The cost-effectiveness of ARGX-113 as second line treatment for adult chronic primary immune thrombocytopenia in the United Kingdom. Master's Thesis / Essay, Pharmacy.

[img] Text
Eindversie_Matthijs_Fledderus_s2151944.docx
Restricted to Registered users only

Download (1MB)

Abstract

The supervisor and/or the author did not authorize public publication of the thesis.

Item Type: Thesis (Master's Thesis / Essay)
Supervisor:
Supervisor nameSupervisor E mail
Postma, M.J.UNSPECIFIED
Dvortsin, E.UNSPECIFIED
Supervisor (outside RUG):
Supervisor outside RUG nameSupervisor outside RUG E mail
Lemmen, A.UNSPECIFIED
Degree programme: Pharmacy
Thesis type: Master's Thesis / Essay
Language: English
Date Deposited: 15 May 2018 09:28
Last Modified: 15 May 2018 09:28
URI: http://fse.studenttheses.ub.rug.nl/id/eprint/17028

Actions (login required)

View Item View Item